PORTFOLIO OF COMPANIES

Estracure, Inc.

Estracure is a Montreal-based company currently developing next-generation coronary stenting products based on proprietary estrogen-based technologies that minimize restenosis and potentially prevent progression of coronary lesions. With safety an increasingly important consideration with drug-eluting stents, Estracure's novel technology with its enhanced safety profile holds promise as a potential replacement for current-generation drug-eluting stents.

PST, GmbH

PST, GmbH. is a leading German-US medical technology firm dedicated to the safe, non-invasive treatment of osteoarthritis, osteoporosis and orthopedic injuries and associated pain management. PST fits in with Duravest's mission of developing technologies that have a strong basis in safety as well as in cross-disciplinary areas that fall in between traditional medical technology sectors.  Veterinary applications of the technology (PST-VET) are also being offered in the U.S. (click here for more information).